Fas/CD95在磷脂酰肌醇3激酶信号通路下调时定位于脂筏。

Localization of Fas/CD95 into the lipid rafts on down-modulation of the phosphatidylinositol 3-kinase signaling pathway.

作者信息

Bénéteau Marie, Pizon Mathieu, Chaigne-Delalande Benjamin, Daburon Sophie, Moreau Patrick, De Giorgi Francesca, Ichas François, Rebillard Amélie, Dimanche-Boitrel Marie-Thérèse, Taupin Jean-Luc, Moreau Jean-François, Legembre Patrick

机构信息

Centre National de la Recherche Scientifique-Unite Mixte de Recherche 5164, 33076 Bordeaux, France.

出版信息

Mol Cancer Res. 2008 Apr;6(4):604-13. doi: 10.1158/1541-7786.MCR-07-0331.

Abstract

Activation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway is known to protect tumor cells from apoptosis and more specifically from the Fas-mediated apoptotic signal. The antitumoral agent edelfosine sensitizes leukemic cells to death by inducing the redistribution of the apoptotic receptor Fas into plasma membrane subdomains called lipid rafts. Herein, we show that inhibition of the PI3K signal by edelfosine triggers a Fas-mediated apoptotic signal independently of the Fas/FasL interaction. Furthermore, similarly to edelfosine, blockade of the PI3K activity, using specific inhibitors LY294002 and wortmannin, leads to the clustering of Fas whose supramolecular complex is colocalized within the lipid rafts. These findings indicate that the antitumoral agent edelfosine down-modulates the PI3K signal to sensitize tumor cells to death through the redistribution of Fas into large platform of membrane rafts.

摘要

已知磷脂酰肌醇3-激酶(PI3K)信号通路的激活可保护肿瘤细胞免于凋亡,更具体地说是免受Fas介导的凋亡信号影响。抗肿瘤药物依地福新通过诱导凋亡受体Fas重新分布到称为脂筏的质膜亚结构域中,使白血病细胞对死亡敏感。在此,我们表明依地福新对PI3K信号的抑制独立于Fas/FasL相互作用触发Fas介导的凋亡信号。此外,与依地福新类似,使用特异性抑制剂LY294002和渥曼青霉素阻断PI3K活性会导致Fas聚集,其超分子复合物共定位于脂筏内。这些发现表明,抗肿瘤药物依地福新通过将Fas重新分布到膜筏的大平台中,下调PI3K信号以使肿瘤细胞对死亡敏感。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索